Altenburg, A.F.; Kreijtz, J.H.C.M.; De Vries, R.D.; Song, F.; Fux, R.; Rimmelzwaan, G.F.; Sutter, G.; Volz, A.
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases. Viruses 2014, 6, 2735-2761.
https://doi.org/10.3390/v6072735
AMA Style
Altenburg AF, Kreijtz JHCM, De Vries RD, Song F, Fux R, Rimmelzwaan GF, Sutter G, Volz A.
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases. Viruses. 2014; 6(7):2735-2761.
https://doi.org/10.3390/v6072735
Chicago/Turabian Style
Altenburg, Arwen F., Joost H. C. M. Kreijtz, Rory D. De Vries, Fei Song, Robert Fux, Guus F. Rimmelzwaan, Gerd Sutter, and Asisa Volz.
2014. "Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases" Viruses 6, no. 7: 2735-2761.
https://doi.org/10.3390/v6072735
APA Style
Altenburg, A. F., Kreijtz, J. H. C. M., De Vries, R. D., Song, F., Fux, R., Rimmelzwaan, G. F., Sutter, G., & Volz, A.
(2014). Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases. Viruses, 6(7), 2735-2761.
https://doi.org/10.3390/v6072735